Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
CA Stock MarketDetailed Quotes
EPRX Eupraxia Pharmaceuticals Inc
- 5.510
- +0.010+0.18%
15min DelayMarket Closed May 2 16:00 ET
197.53MMarket Cap-5.04P/E (TTM)
5.550High5.480Low11.31KVolume5.520Open5.500Pre Close62.33KTurnover6.49052wk High0.05%Turnover Ratio35.85MShares3.07052wk Low-1.093EPS TTM137.29MFloat Cap9.100Historical HighLossP/E (Static)24.92MShs Float0.800Historical Low-1.093EPS LYR1.27%Amplitude--Dividend TTM84.77P/B1Lot Size--Div YieldTTM
Eupraxia Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -44.56%-29.99M | 1.00%-5.97M | -73.40%-10.19M | -80.53%-7.71M | -34.01%-6.12M | -44.14%-20.75M | -33.13%-6.03M | -48.46%-5.88M | -52.89%-4.27M | -46.79%-4.57M |
| Net income from continuing operations | 11.12%-25.74M | 28.99%-7.53M | -22.37%-5.99M | 36.21%-6.06M | -55.63%-6.16M | -52.53%-28.97M | -25.67%-10.61M | -77.48%-4.9M | -98.88%-9.51M | -31.37%-3.96M |
| Operating gains losses | 330.04%137.48K | -27.73%-75.54K | 957.84%9.95K | 190.79%58.15K | 844.56%144.91K | 72.44%-59.76K | -274.22%-59.14K | 99.46%-1.16K | 122.32%20K | -136.25%-19.46K |
| Depreciation and amortization | 10.41%171.72K | 32.20%54.51K | -2.47%37.76K | 10.25%42.03K | -0.10%37.42K | 5.16%155.53K | -12.04%41.23K | 19.06%38.72K | 3.12%38.12K | 18.79%37.46K |
| Unrealized gains and losses of investment securities | -243.50%-1.2M | --0 | --0 | -111.79%-430.5K | -345.17%-770.04K | -20.79%836.6K | -210.61%-1.25M | ---1.88M | --3.65M | --314.08K |
| Remuneration paid in stock | 128.25%3.22M | 231.83%1.03M | 41.34%507.25K | 246.13%1.47M | -32.86%213.13K | -1.50%1.41M | -57.74%309.84K | 342.94%358.88K | 115.21%426.12K | -24.71%317.42K |
| Other non cashItems | -64.96%182.57K | -110.30%-15.85K | -117.28%-14.23K | -59.15%51.7K | 1.68%160.94K | -21.05%521.01K | -49.90%153.84K | 396.20%82.33K | -28.94%126.56K | -21.87%158.29K |
| Change In working capital | -226.40%-6.76M | -89.56%568.72K | -1,446.57%-4.74M | -392.93%-2.84M | 117.63%250.12K | 253.35%5.35M | 228.71%5.45M | 135.35%351.93K | -41.58%971.06K | -75.31%-1.42M |
| -Change in receivables | 2.24%-101.39K | -47.09%-182.69K | 382.61%50.43K | -62.70%13.67K | 919.02%17.2K | -145.00%-103.71K | -161.53%-124.21K | -41.53%-17.85K | -22.29%36.65K | 128.34%1.69K |
| -Change in prepaid assets | -674.63%-948.42K | -1,907.53%-119.41K | -198.29%-69.46K | -270.84%-884.76K | 143.49%125.2K | -206.40%-122.44K | -113.35%-5.95K | -40.50%70.67K | -17.27%-238.58K | 31,838.22%51.42K |
| -Change in payables and accrued expense | -202.46%-5.71M | -84.39%870.82K | -1,678.03%-4.72M | -268.24%-1.97M | 107.32%107.71K | 321.28%5.58M | 295.35%5.58M | 127.15%299.11K | -35.50%1.17M | -83.18%-1.47M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -44.56%-29.99M | -0.13%-5.97M | -71.41%-10.19M | -80.53%-7.71M | -34.01%-6.12M | -44.14%-20.75M | -31.63%-5.96M | -50.18%-5.94M | -52.89%-4.27M | -46.79%-4.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2.43%-75.16K | 11.40%-43.76K | -340.27%-42.28K | 379.37%17.66K | 15.85%-6.79K | -100.75%-73.38K | -100.30%-49.39K | -102.57%-9.6K | 99.91%-6.32K | -48.63%-8.07K |
| Net PPE purchase and sale | -2.43%-75.16K | 11.40%-43.76K | -340.27%-42.28K | 379.37%17.66K | 15.85%-6.79K | 68.82%-73.38K | 31.75%-49.39K | 67.34%-9.6K | 95.07%-6.32K | -48.63%-8.07K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -2.43%-75.16K | 11.40%-43.76K | -340.27%-42.28K | 379.37%17.66K | 15.85%-6.79K | -100.75%-73.38K | -100.30%-49.39K | -102.57%-9.6K | 99.91%-6.32K | -48.63%-8.07K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 117.20%45.78M | 532,658.26%31.73M | -128.25%-4.6M | -198.01%-4.5M | 11,797.52%23.15M | 95.16%21.08M | -99.49%5.96K | 2,698.96%16.29M | -55.37%4.59M | 638.09%194.61K |
| Net issuance payments of debt | -11,402.20%-9.14M | --0 | -22,915.61%-4.6M | -127,324.75%-4.5M | -3.36%-36.82K | 44.16%-79.44K | 51.52%-20.3K | 33.71%-19.99K | 89.64%-3.53K | 1.51%-35.62K |
| Net common stock issuance | 243.43%54.56M | --31.71M | --0 | --0 | --22.85M | 49.36%15.89M | --0 | 2,763.14%15.89M | --0 | --0 |
| Proceeds from stock option exercised by employees | -93.11%363.06K | -1.49%25.86K | --0 | --0 | 46.46%337.2K | 1,618.51%5.27M | -91.44%26.25K | --421K | --4.59M | --230.23K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 117.20%45.78M | 532,658.26%31.73M | -128.25%-4.6M | -198.01%-4.5M | 11,797.52%23.15M | 95.16%21.08M | -99.49%5.96K | 2,698.96%16.29M | -55.37%4.59M | 638.09%194.61K |
| Net cash flow | ||||||||||
| Beginning cash position | 5.90%19.34M | -64.74%8.66M | 61.66%23.32M | 157.81%35.91M | 5.90%19.34M | 45.75%18.26M | 184.60%24.56M | 6.85%14.42M | 3.01%13.93M | 9.14%18.26M |
| Current changes in cash | 6,015.33%15.71M | 528.00%25.71M | -243.55%-14.83M | -4,001.35%-12.19M | 488.67%17.03M | -95.88%256.97K | -145.45%-6.01M | 345.39%10.33M | -19.04%312.55K | -38.94%-4.38M |
| Effect of exchange rate changes | -338.01%-1.96M | -262.18%-1.28M | 192.83%178.86K | -317.86%-397.62K | -1,122.24%-460.76K | 261.89%821.4K | 193.67%786.49K | -168.51%-192.68K | 64.46%182.51K | 175.10%45.07K |
| End cash Position | 71.14%33.1M | 71.14%33.1M | -64.74%8.66M | 61.66%23.32M | 157.81%35.91M | 5.90%19.34M | 5.90%19.34M | 184.60%24.56M | 6.85%14.42M | 3.01%13.93M |
| Free cash from | -44.55%-30.1M | -0.04%-6.02M | -71.84%-10.23M | -80.51%-7.72M | -33.92%-6.13M | -42.32%-20.82M | -30.63%-6.01M | -49.32%-5.95M | -46.39%-4.28M | -46.80%-4.58M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts